Vital Signs: Reaching People Who Could Benefit From PrEP


The content included below is available for historical purposes. CDC is no longer updating this content. Please refer to the most updated CDC PrEP guidance.

November 24, 2015 – New CDC Estimates Underscore the Need to increase Awareness of a Daily Pill that can Prevent HIV Infection

In advance of World AIDS Day (observed Tuesday, December 1), CDC has published new data that estimate 1 in 4 gay, bisexual men; 1 in 5 people who inject drugs; and 1 in 200 heterosexuals should be counseled about pre-exposure prophylaxis, a daily pill that can prevent HIV infection.



Graphic: Vital Signs – Reaching People Who Could Benefit From PrEP

The following graphic highlights major findings from CDC’s analysis. The high-resolution, public domain image is ready to download and print in your publication. Click on the graphic to see it in high-resolution.

This image is in the public domain and thus free of any copyright restrictions. As a matter of courtesy, we ask that the content provider be credited and notified of any public or private usage of an image.

Thumbnail of Vital Signs PrEP Graphic showing statics for clinicians about use of PrEP to prevent HIV

Not Enough health care providers know about PrEP
View High Resolution Versionimage icon
This graphic illustrates that not enough health care providers know about pre-exposure prophylaxis (PrEP). Daily PrEP can reduce the risk of sexually acquired HIV by more than 90% and reduce the risk of HIV infection among injection drug users by more than 70%. Additionally, one in three primary care doctors and nurses have not heard about PrEP.


Page last reviewed: December 21, 2021